Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 13 studies | 28% ± 10% | |
lung | 9 studies | 25% ± 8% | |
lymph node | 5 studies | 25% ± 4% | |
kidney | 4 studies | 19% ± 3% | |
intestine | 4 studies | 24% ± 13% | |
pancreas | 3 studies | 28% ± 3% | |
liver | 3 studies | 34% ± 22% | |
breast | 3 studies | 18% ± 1% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
adrenal gland | 100% | 5840.02 | 258 / 258 | 100% | 122.32 | 230 / 230 |
esophagus | 100% | 9592.02 | 1445 / 1445 | 100% | 128.38 | 183 / 183 |
ovary | 100% | 7407.21 | 180 / 180 | 100% | 275.06 | 430 / 430 |
pancreas | 100% | 3434.38 | 328 / 328 | 100% | 147.67 | 178 / 178 |
thymus | 100% | 6149.67 | 653 / 653 | 100% | 168.31 | 605 / 605 |
uterus | 100% | 7925.44 | 170 / 170 | 100% | 170.70 | 459 / 459 |
skin | 100% | 4930.76 | 1808 / 1809 | 100% | 179.42 | 472 / 472 |
kidney | 100% | 5788.80 | 89 / 89 | 100% | 133.48 | 898 / 901 |
prostate | 100% | 7936.96 | 245 / 245 | 100% | 196.26 | 500 / 502 |
intestine | 100% | 9981.77 | 966 / 966 | 99% | 159.94 | 524 / 527 |
stomach | 100% | 6187.27 | 359 / 359 | 99% | 153.13 | 284 / 286 |
breast | 100% | 6966.82 | 459 / 459 | 99% | 169.94 | 1110 / 1118 |
brain | 99% | 3653.09 | 2623 / 2642 | 100% | 133.02 | 705 / 705 |
lung | 100% | 5693.71 | 577 / 578 | 99% | 158.41 | 1147 / 1155 |
liver | 99% | 2284.45 | 224 / 226 | 100% | 114.66 | 406 / 406 |
bladder | 100% | 9553.52 | 21 / 21 | 99% | 180.78 | 498 / 504 |
adipose | 100% | 7025.46 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 9527.24 | 1335 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 299.74 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 203.83 | 29 / 29 |
muscle | 100% | 13393.74 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 6843.55 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 152.89 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 226.97 | 1 / 1 |
peripheral blood | 100% | 5640.14 | 928 / 929 | 0% | 0 | 0 / 0 |
heart | 100% | 7624.70 | 858 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0016480 | Biological process | negative regulation of transcription by RNA polymerase III |
GO_0016479 | Biological process | negative regulation of transcription by RNA polymerase I |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0000994 | Molecular function | RNA polymerase III core binding |
GO_0001002 | Molecular function | RNA polymerase III type 1 promoter sequence-specific DNA binding |
GO_0001003 | Molecular function | RNA polymerase III type 2 promoter sequence-specific DNA binding |
GO_0005515 | Molecular function | protein binding |
GO_0001006 | Molecular function | RNA polymerase III type 3 promoter sequence-specific DNA binding |
Gene name | MAF1 |
Protein name | Repressor of RNA polymerase III transcription MAF1 homolog Repressor of RNA polymerase III transcription MAF1 |
Synonyms | |
Description | FUNCTION: Plays a role in the repression of RNA polymerase III-mediated transcription in response to changing nutritional, environmental and cellular stress conditions to balance the production of highly abundant tRNAs, 5S rRNA, and other small non-coding RNAs with cell growth and maintenance . Also plays a key role in cell fate determination by promoting mesorderm induction and adipocyte differentiation (By similarity). Mechanistically, associates with the RNA polymerase III clamp and thereby impairs its recruitment to the complex made of the promoter DNA, TBP and the initiation factor TFIIIB . When nutrients are available and mTOR kinase is active, MAF1 is hyperphosphorylated and RNA polymerase III is engaged in transcription. Stress-induced MAF1 dephosphorylation results in nuclear localization, increased targeting of gene-bound RNA polymerase III and a decrease in the transcriptional readout . Additionally, may also regulate RNA polymerase I and RNA polymerase II-dependent transcription through its ability to regulate expression of the central initiation factor TBP . . FUNCTION: Element of the TORC1 signaling pathway that acts as a mediator of diverse signals and that represses RNA polymerase III transcription. Inhibits the de novo assembly of TFIIIB onto DNA. . |
Accessions | ENST00000322428.10 ENST00000527572.5 E9PJ05 ENST00000534585.5 ENST00000534811.1 H0YEV4 Q9H063 E9PSH4 E9PR76 ENST00000527058.1 ENST00000532522.5 |